Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.264 EUR | -0.47% | -0.94% | -31.64% |
Business Summary
Number of employees: 105
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Epicutaneous Immunotherapy Products
100.0
%
| 5 | 100.0 % | 15 | 100.0 % | +215.64% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 5 | 100.0 % | 15 | 100.0 % | +215.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tassé
CEO | Chief Executive Officer | 64 | 18-11-28 |
Director of Finance/CFO | 54 | Nov. 05 | |
Pharis Mohideen
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-07-21 |
Pascale Ehouarn
CTO | Chief Tech/Sci/R&D Officer | - | 05-12-31 |
Katie Matthews
IRC | Investor Relations Contact | - | - |
Pascal Wotling
PRN | Corporate Officer/Principal | - | 20-03-31 |
General Counsel | - | 21-02-21 | |
Caroline Daniere
HRO | Human Resources Officer | 50 | 19-09-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Morris
BRD | Director/Board Member | 61 | 21-02-28 |
Michel de Rosen
CHM | Chairman | 73 | 18-06-21 |
Don Soland
BRD | Director/Board Member | 65 | 15-03-05 |
Michael Goller
BRD | Director/Board Member | 49 | 15-10-20 |
Daniel Tassé
CEO | Chief Executive Officer | 64 | 18-11-28 |
Maïlys Ferrère
BRD | Director/Board Member | 60 | 16-06-20 |
Director/Board Member | 64 | 22-10-02 | |
Julie O'Neill
BRD | Director/Board Member | 58 | 17-06-14 |
Ravi Rao
BRD | Director/Board Member | 55 | 21-05-18 |
Adora Ndu
BRD | Director/Board Member | 43 | 21-05-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,250,954 | 86,727,703 ( 90.11 %) | 149,793 ( 0.1556 %) | 90.11 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DBV TECHNOLOGIES 0.16% | 149,793 | 0.16% | 215,324 $ |
Company contact information
DBV Technologies SA
177-181, avenue Pierre Brossolette
92120, Montrouge
+33 1 55 42 78 78
http://www.dbv-technologies.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.64% | 130M | |
+0.62% | 68.09B | |
+11.18% | 9.08B | |
-19.62% | 4.57B | |
+24.23% | 3.9B | |
-0.44% | 3.69B | |
+30.04% | 2.62B | |
-25.01% | 2.34B | |
-28.30% | 2.14B | |
+1.33% | 1.84B |
- Stock Market
- Equities
- DBV Stock
- Company DBV Technologies